Skip to main content
The BMJ logoLink to The BMJ
letter
. 1991 May 11;302(6785):1150–1151. doi: 10.1136/bmj.302.6785.1150-b

Chronic paranoid psychosis after misuse of MDMA.

A R Winstock
PMCID: PMC1669834  PMID: 1675133

Full text

PDF
1150

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Climko R. P., Roehrich H., Sweeney D. R., Al-Razi J. Ecstacy: a review of MDMA and MDA. Int J Psychiatry Med. 1986;16(4):359–372. doi: 10.2190/dcrp-u22m-aumd-d84h. [DOI] [PubMed] [Google Scholar]
  2. Hayner G. N., McKinney H. MDMA. The dark side of ecstasy. J Psychoactive Drugs. 1986 Oct-Dec;18(4):341–347. doi: 10.1080/02791072.1986.10472367. [DOI] [PubMed] [Google Scholar]
  3. McGuire P., Fahy T. Chronic paranoid psychosis after misuse of MDMA ("ecstasy") BMJ. 1991 Mar 23;302(6778):697–697. doi: 10.1136/bmj.302.6778.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. McKenna D. J., Peroutka S. J. Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). J Neurochem. 1990 Jan;54(1):14–22. doi: 10.1111/j.1471-4159.1990.tb13277.x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES